%PDF-1.7
%
1950 0 obj
<<
/S /GoTo
/D [1105 0 R /XYZ 0 792 null]
>>
endobj
1951 0 obj
<<
/A 1952 0 R
/Count 0
/Next 1949 0 R
/Prev 1628 0 R
/Title (Appendix 2 Schedule of PD Assessments)
/Parent 1626 0 R
/F 0
/C [0 0 0]
>>
endobj
1948 0 obj
<<
/A 1953 0 R
/Count 0
/Prev 1947 0 R
/Title (Missing School/Daycare Questions)
/Parent 1945 0 R
/F 0
/C [0 0 0]
>>
endobj
1949 0 obj
<<
/A 1950 0 R
/Count 0
/Next 1945 0 R
/Prev 1951 0 R
/Title (Appendix 3 Haemo-QoL-SF \(United States/English\))
/Parent 1626 0 R
/F 0
/C [0 0 0]
>>
endobj
1946 0 obj
<<
/S /GoTo
/D [1110 0 R /XYZ 0 792 null]
>>
endobj
1947 0 obj
<<
/A 1954 0 R
/Count 0
/Next 1948 0 R
/Title (Adapted INHIB-QoL Questionnaire Screens)
/Parent 1945 0 R
/F 0
/C [0 0 0]
>>
endobj
1944 0 obj
<<
/S /GoTo
/D [1122 0 R /XYZ 0 612 null]
>>
endobj
1945 0 obj
<<
/C [0 0 0]
/Parent 1626 0 R
/A 1946 0 R
/Last 1948 0 R
/First 1947 0 R
/Count 2
/Title (Appendix 4 Adapted InhibQoL Including Aspects of Caregiver Burden \(United States/English\))
/Prev 1949 0 R
/Next 1943 0 R
/F 0
>>
endobj
1942 0 obj
<<
/S /GoTo
/D [1142 0 R /XYZ 0 792 null]
>>
endobj
1943 0 obj
<<
/A 1944 0 R
/Count 0
/Next 1629 0 R
/Prev 1945 0 R
/Title (Appendix 5 WHO Toxicity Grading Scale for Determining the Severity of Laboratory Abnormalities and Adverse Events)
/Parent 1626 0 R
/F 0
/C [0 0 0]
>>
endobj
1940 0 obj
<<
/S /GoTo
/D [681 0 R /XYZ 0 792 null]
>>
endobj
1941 0 obj
<<
/S /GoTo
/D [613 0 R /XYZ 0 792 null]
>>
endobj
1938 0 obj
<<
/S /GoTo
/D [720 0 R /XYZ 0 792 null]
>>
endobj
1939 0 obj
<<
/S /GoTo
/D [667 0 R /XYZ 0 792 null]
>>
endobj
1936 0 obj
<<
/S /GoTo
/D [870 0 R /XYZ 0 792 null]
>>
endobj
1937 0 obj
<<
/A 1938 0 R
/Count 0
/Next 1935 0 R
/Prev 1636 0 R
/Title (Table 2 Simulated Median Pharmacokinetic Parameters)
/Parent 1634 0 R
/F 0
/C [0 0 0]
>>
endobj
1934 0 obj
<<
/S /GoTo
/D [884 0 R /XYZ 0 792 null]
>>
endobj
1935 0 obj
<<
/A 1936 0 R
/Count 0
/Next 1933 0 R
/Prev 1937 0 R
/Title (Table 3 Guidelines for Management of Specific Adverse Events)
/Parent 1634 0 R
/F 0
/C [0 0 0]
>>
endobj
1932 0 obj
<<
/S /GoTo
/D [923 0 R /XYZ 0 792 null]
>>
endobj
1933 0 obj
<<
/A 1934 0 R
/Count 0
/Next 1637 0 R
/Prev 1935 0 R
/Title (Table 4 Coagulation Test Results Affected and Unaffected by Emicizumab)
/Parent 1634 0 R
/F 0
/C [0 0 0]
>>
endobj
1930 0 obj
<<
/S /GoTo
/D [1059 0 R /XYZ 0 792 null]
>>
endobj
1931 0 obj
<<
/S /GoTo
/D [1059 0 R /XYZ 0 792 null]
>>
endobj
1928 0 obj
<<
/S /GoTo
/D [1059 0 R /XYZ 0 792 null]
>>
endobj
1929 0 obj
<<
/A 1930 0 R
/Count 0
/Next 1927 0 R
/Prev 1642 0 R
/Title (9.2 Protocol Deviations)
/Parent 1640 0 R
/F 0
/C [0 0 0]
>>
endobj
1926 0 obj
<<
/S /GoTo
/D [1059 0 R /XYZ 0 792 null]
>>
endobj
1927 0 obj
<<
/A 1928 0 R
/Count 0
/Next 1925 0 R
/Prev 1929 0 R
/Title (9.3 Site Inspections)
/Parent 1640 0 R
/F 0
/C [0 0 0]
>>
endobj
1924 0 obj
<<
/S /GoTo
/D [1061 0 R /XYZ 0 792 null]
>>
endobj
1925 0 obj
<<
/A 1926 0 R
/Count 0
/Next 1923 0 R
/Prev 1927 0 R
/Title (9.4 Administrative Structure)
/Parent 1640 0 R
/F 0
/C [0 0 0]
>>
endobj
1922 0 obj
<<
/S /GoTo
/D [1061 0 R /XYZ 0 792 null]
>>
endobj
1923 0 obj
<<
/A 1924 0 R
/Count 0
/Next 1921 0 R
/Prev 1925 0 R
/Title (9.5 Joint Monitoring Committee)
/Parent 1640 0 R
/F 0
/C [0 0 0]
>>
endobj
1920 0 obj
<<
/S /GoTo
/D [1068 0 R /XYZ 0 792 null]
>>
endobj
1921 0 obj
<<
/A 1922 0 R
/Count 0
/Next 1643 0 R
/Prev 1923 0 R
/Title (9.6 Publication of Data and Protection of Trade Secrets)
/Parent 1640 0 R
/F 0
/C [0 0 0]
>>
endobj
1956 0 obj
<<
/S /GoTo
/D [70 0 R /XYZ 0 792 null]
>>
endobj
1954 0 obj
<<
/S /GoTo
/D [1110 0 R /XYZ 0 792 null]
>>
endobj
1955 0 obj
<<
/S /GoTo
/D [1082 0 R /XYZ 0 612 null]
>>
endobj
1952 0 obj
<<
/S /GoTo
/D [1100 0 R /XYZ 0 792 null]
>>
endobj
1953 0 obj
<<
/S /GoTo
/D [1120 0 R /XYZ 0 792 null]
>>
endobj
1822 0 obj
<<
/S /GoTo
/D [966 0 R /XYZ 0 792 null]
>>
endobj
1823 0 obj
<<
/A 1824 0 R
/Count 0
/Next 1821 0 R
/Prev 1825 0 R
/Title (5.3.5.9 Preexisting Medical Conditions)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1820 0 obj
<<
/S /GoTo
/D [966 0 R /XYZ 0 792 null]
>>
endobj
1821 0 obj
<<
/A 1822 0 R
/Count 0
/Next 1819 0 R
/Prev 1823 0 R
/Title (5.3.5.10 Lack of Efficacy or Worsening of Hemophilic Bleeds)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1818 0 obj
<<
/S /GoTo
/D [971 0 R /XYZ 0 792 null]
>>
endobj
1819 0 obj
<<
/A 1820 0 R
/Count 0
/Next 1817 0 R
/Prev 1821 0 R
/Title (5.3.5.11 Hospitalization or Prolonged Hospitalization)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1816 0 obj
<<
/S /GoTo
/D [971 0 R /XYZ 0 792 null]
>>
endobj
1817 0 obj
<<
/A 1818 0 R
/Count 0
/Next 1809 0 R
/Prev 1819 0 R
/Title (5.3.5.12 Adverse Events Associated with an Overdose or Error in Drug Administration)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1814 0 obj
<<
/A 1815 0 R
/Count 0
/Next 1812 0 R
/Prev 1797 0 R
/Title (5.3.2 Eliciting Adverse Event Information)
/Parent 1795 0 R
/F 0
/C [0 0 0]
>>
endobj
1815 0 obj
<<
/S /GoTo
/D [923 0 R /XYZ 0 792 null]
>>
endobj
1812 0 obj
<<
/A 1813 0 R
/Count 0
/Next 1810 0 R
/Prev 1814 0 R
/Title (5.3.3 Assessment of Severity of Adverse Events)
/Parent 1795 0 R
/F 0
/C [0 0 0]
>>
endobj
1813 0 obj
<<
/S /GoTo
/D [923 0 R /XYZ 0 792 null]
>>
endobj
1810 0 obj
<<
/A 1811 0 R
/Count 0
/Next 1798 0 R
/Prev 1812 0 R
/Title (5.3.4 Assessment of Causality of Adverse Events)
/Parent 1795 0 R
/F 0
/C [0 0 0]
>>
endobj
1811 0 obj
<<
/S /GoTo
/D [936 0 R /XYZ 0 792 null]
>>
endobj
1808 0 obj
<<
/A 1839 0 R
/Count 0
/Next 1837 0 R
/Title (5.3.5.1 Injection-Site Reactions)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1809 0 obj
<<
/A 1816 0 R
/Count 0
/Prev 1817 0 R
/Title (5.3.5.13 Patient-Reported Outcome Data)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1806 0 obj
<<
/S /GoTo
/D [884 0 R /XYZ 0 792 null]
>>
endobj
1807 0 obj
<<
/S /GoTo
/D [936 0 R /XYZ 0 792 null]
>>
endobj
1804 0 obj
<<
/A 1805 0 R
/Count 0
/Next 1802 0 R
/Prev 1801 0 R
/Title (5.2.2 Serious Adverse Events \(Immediately Reportable to the Sponsor\))
/Parent 1799 0 R
/F 0
/C [0 0 0]
>>
endobj
1805 0 obj
<<
/S /GoTo
/D [893 0 R /XYZ 0 792 null]
>>
endobj
1802 0 obj
<<
/A 1803 0 R
/Count 0
/Prev 1804 0 R
/Title (5.2.3 Adverse Events of Special Interest \(Immediately Reportable to the Sponsor\))
/Parent 1799 0 R
/F 0
/C [0 0 0]
>>
endobj
1803 0 obj
<<
/S /GoTo
/D [900 0 R /XYZ 0 792 null]
>>
endobj
1800 0 obj
<<
/S /GoTo
/D [884 0 R /XYZ 0 792 null]
>>
endobj
1801 0 obj
<<
/A 1806 0 R
/Count 0
/Next 1804 0 R
/Title (5.2.1 Adverse Events)
/Parent 1799 0 R
/F 0
/C [0 0 0]
>>
endobj
1798 0 obj
<<
/C [0 0 0]
/Parent 1795 0 R
/A 1807 0 R
/Last 1809 0 R
/First 1808 0 R
/Count 13
/Title (5.3.5 Procedures for Recording Adverse Events)
/Prev 1810 0 R
/F 0
>>
endobj
1799 0 obj
<<
/C [0 0 0]
/Parent 1656 0 R
/A 1800 0 R
/Last 1802 0 R
/First 1801 0 R
/Count 3
/Title (5.2 Safety Parameters and Definitions)
/Prev 1658 0 R
/Next 1795 0 R
/F 0
>>
endobj
1796 0 obj
<<
/S /GoTo
/D [900 0 R /XYZ 0 792 null]
>>
endobj
1797 0 obj
<<
/A 1840 0 R
/Count 0
/Next 1814 0 R
/Title (5.3.1 Adverse Event Reporting Period)
/Parent 1795 0 R
/F 0
/C [0 0 0]
>>
endobj
1794 0 obj
<<
/C [0 0 0]
/Parent 1791 0 R
/A 1841 0 R
/Last 1843 0 R
/First 1842 0 R
/Count 4
/Title (5.4.3 Reporting Requirements for Pregnancies)
/Prev 1844 0 R
/F 0
>>
endobj
1795 0 obj
<<
/C [0 0 0]
/Parent 1656 0 R
/A 1796 0 R
/Last 1798 0 R
/First 1797 0 R
/Count 18
/Title (5.3 Methods and Timing for Capturing and Assessing Safety Parameters)
/Prev 1799 0 R
/Next 1791 0 R
/F 0
>>
endobj
1792 0 obj
<<
/S /GoTo
/D [971 0 R /XYZ 0 792 null]
>>
endobj
1793 0 obj
<<
/C [0 0 0]
/Parent 1791 0 R
/A 1856 0 R
/Last 1857 0 R
/First 1857 0 R
/Count 1
/Title (5.4.1 Emergency Medical Contacts)
/Next 1844 0 R
/F 0
>>
endobj
1854 0 obj
<<
/S /GoTo
/D [991 0 R /XYZ 0 792 null]
>>
endobj
1855 0 obj
<<
/S /GoTo
/D [991 0 R /XYZ 0 792 null]
>>
endobj
1852 0 obj
<<
/S /GoTo
/D [1000 0 R /XYZ 0 792 null]
>>
endobj
1853 0 obj
<<
/A 1854 0 R
/Count 0
/Next 1851 0 R
/Prev 1842 0 R
/Title (5.4.3.2 Pregnancies in Female Partners of Male Patients)
/Parent 1794 0 R
/F 0
/C [0 0 0]
>>
endobj
1850 0 obj
<<
/S /GoTo
/D [1000 0 R /XYZ 0 792 null]
>>
endobj
1851 0 obj
<<
/A 1852 0 R
/Count 0
/Next 1843 0 R
/Prev 1853 0 R
/Title (5.4.3.3 Abortions)
/Parent 1794 0 R
/F 0
/C [0 0 0]
>>
endobj
1848 0 obj
<<
/S /GoTo
/D [991 0 R /XYZ 0 792 null]
>>
endobj
1849 0 obj
<<
/S /GoTo
/D [978 0 R /XYZ 0 792 null]
>>
endobj
1846 0 obj
<<
/A 1849 0 R
/Count 0
/Next 1847 0 R
/Title (5.4.2.1 Events That Occur prior to Study Drug Initiation)
/Parent 1844 0 R
/F 0
/C [0 0 0]
>>
endobj
1847 0 obj
<<
/A 1848 0 R
/Count 0
/Prev 1846 0 R
/Title (5.4.2.2 Events That Occur after Study Drug Initiation)
/Parent 1844 0 R
/F 0
/C [0 0 0]
>>
endobj
1844 0 obj
<<
/C [0 0 0]
/Parent 1791 0 R
/A 1845 0 R
/Last 1847 0 R
/First 1846 0 R
/Count 2
/Title (5.4.2 Reporting Requirements for Serious Adverse Events and Adverse Events of Special Interest)
/Prev 1793 0 R
/Next 1794 0 R
/F 0
>>
endobj
1845 0 obj
<<
/S /GoTo
/D [978 0 R /XYZ 0 792 null]
>>
endobj
1842 0 obj
<<
/A 1855 0 R
/Count 0
/Next 1853 0 R
/Title (5.4.3.1 Pregnancies in Female Patients)
/Parent 1794 0 R
/F 0
/C [0 0 0]
>>
endobj
1843 0 obj
<<
/A 1850 0 R
/Count 0
/Prev 1851 0 R
/Title (5.4.3.4 Congenital Anomalies/Birth Defects)
/Parent 1794 0 R
/F 0
/C [0 0 0]
>>
endobj
1840 0 obj
<<
/S /GoTo
/D [900 0 R /XYZ 0 792 null]
>>
endobj
1841 0 obj
<<
/S /GoTo
/D [991 0 R /XYZ 0 792 null]
>>
endobj
1838 0 obj
<<
/S /GoTo
/D [936 0 R /XYZ 0 792 null]
>>
endobj
1839 0 obj
<<
/S /GoTo
/D [936 0 R /XYZ 0 792 null]
>>
endobj
1836 0 obj
<<
/S /GoTo
/D [941 0 R /XYZ 0 792 null]
>>
endobj
1837 0 obj
<<
/A 1838 0 R
/Count 0
/Next 1835 0 R
/Prev 1808 0 R
/Title (5.3.5.2 Diagnosis versus Signs and Symptoms)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1834 0 obj
<<
/S /GoTo
/D [941 0 R /XYZ 0 792 null]
>>
endobj
1835 0 obj
<<
/A 1836 0 R
/Count 0
/Next 1833 0 R
/Prev 1837 0 R
/Title (5.3.5.3 Adverse Events That Are Secondary to Other Events)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1832 0 obj
<<
/S /GoTo
/D [946 0 R /XYZ 0 792 null]
>>
endobj
1833 0 obj
<<
/A 1834 0 R
/Count 0
/Next 1831 0 R
/Prev 1835 0 R
/Title (5.3.5.4 Persistent or Recurrent Adverse Events)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1830 0 obj
<<
/S /GoTo
/D [946 0 R /XYZ 0 792 null]
>>
endobj
1831 0 obj
<<
/A 1832 0 R
/Count 0
/Next 1829 0 R
/Prev 1833 0 R
/Title (5.3.5.5 Abnormal Laboratory Values)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1828 0 obj
<<
/S /GoTo
/D [953 0 R /XYZ 0 792 null]
>>
endobj
1829 0 obj
<<
/A 1830 0 R
/Count 0
/Next 1827 0 R
/Prev 1831 0 R
/Title (5.3.5.6 Abnormal Vital Sign Values)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1826 0 obj
<<
/S /GoTo
/D [953 0 R /XYZ 0 792 null]
>>
endobj
1827 0 obj
<<
/A 1828 0 R
/Count 0
/Next 1825 0 R
/Prev 1829 0 R
/Title (5.3.5.7 Abnormal Liver Function Tests)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1824 0 obj
<<
/S /GoTo
/D [966 0 R /XYZ 0 792 null]
>>
endobj
1825 0 obj
<<
/A 1826 0 R
/Count 0
/Next 1823 0 R
/Prev 1827 0 R
/Title (5.3.5.8 Deaths)
/Parent 1798 0 R
/F 0
/C [0 0 0]
>>
endobj
1886 0 obj
<<
/A 1887 0 R
/Count 0
/Next 1884 0 R
/Prev 1888 0 R
/Title (6.5 Safety Analyses)
/Parent 1652 0 R
/F 0
/C [0 0 0]
>>
endobj
1887 0 obj
<<
/S /GoTo
/D [1025 0 R /XYZ 0 792 null]
>>
endobj
1884 0 obj
<<
/A 1885 0 R
/Count 0
/Next 1882 0 R
/Prev 1886 0 R
/Title (6.6 Pharmacokinetic Analyses)
/Parent 1652 0 R
/F 0
/C [0 0 0]
>>
endobj
1885 0 obj
<<
/S /GoTo
/D [1025 0 R /XYZ 0 792 null]
>>
endobj
1882 0 obj
<<
/A 1883 0 R
/Count 0
/Next 1880 0 R
/Prev 1884 0 R
/Title (6.7 Patient-Reported Outcome Analyses)
/Parent 1652 0 R
/F 0
/C [0 0 0]
>>
endobj
1883 0 obj
<<
/S /GoTo
/D [1025 0 R /XYZ 0 792 null]
>>
endobj
1880 0 obj
<<
/A 1881 0 R
/Count 0
/Next 1655 0 R
/Prev 1882 0 R
/Title (6.8 Pharmacodynamic Biomarker Analyses)
/Parent 1652 0 R
/F 0
/C [0 0 0]
>>
endobj
1881 0 obj
<<
/S /GoTo
/D [1030 0 R /XYZ 0 792 null]
>>
endobj
1878 0 obj
<<
/S /GoTo
/D [1030 0 R /XYZ 0 792 null]
>>
endobj
1879 0 obj
<<
/A 1898 0 R
/Count 1
/Last 1899 0 R
/Title (6.9.1 Planned Interim Data Review)
/Parent 1655 0 R
/First 1899 0 R
/F 0
/C [0 0 0]
>>
endobj
1876 0 obj
<<
/S /GoTo
/D [839 0 R /XYZ 0 792 null]
>>
endobj
1877 0 obj
<<
/S /GoTo
/D [837 0 R /XYZ 0 792 null]
>>
endobj
1874 0 obj
<<
/S /GoTo
/D [839 0 R /XYZ 0 792 null]
>>
endobj
1875 0 obj
<<
/A 1876 0 R
/Count 0
/Next 1873 0 R
/Prev 1868 0 R
/Title (5.1.1.2 Hypersensitivity Reaction, Anaphylaxis, Anaphylactoid Reaction)
/Parent 1862 0 R
/F 0
/C [0 0 0]
>>
endobj
1872 0 obj
<<
/S /GoTo
/D [853 0 R /XYZ 0 792 null]
>>
endobj
1873 0 obj
<<
/A 1874 0 R
/Count 0
/Next 1871 0 R
/Prev 1875 0 R
/Title (5.1.1.3 Hypercoagulation and Thromboembolic Events)
/Parent 1862 0 R
/F 0
/C [0 0 0]
>>
endobj
1870 0 obj
<<
/S /GoTo
/D [860 0 R /XYZ 0 792 null]
>>
endobj
1871 0 obj
<<
/A 1872 0 R
/Count 0
/Next 1869 0 R
/Prev 1873 0 R
/Title (5.1.1.4 Thrombotic Microangiopathy)
/Parent 1862 0 R
/F 0
/C [0 0 0]
>>
endobj
1868 0 obj
<<
/A 1877 0 R
/Count 0
/Next 1875 0 R
/Title (5.1.1.1 Injection-Site Reactions)
/Parent 1862 0 R
/F 0
/C [0 0 0]
>>
endobj
1869 0 obj
<<
/A 1870 0 R
/Count 0
/Prev 1871 0 R
/Title (5.1.1.5 Life-Threatening Bleeding Due to Unreliable Standard Coagulation Tests and Inhibitor Assays in the Setting of Emicizumab)
/Parent 1862 0 R
/F 0
/C [0 0 0]
>>
endobj
1866 0 obj
<<
/S /GoTo
/D [870 0 R /XYZ 0 792 null]
>>
endobj
1867 0 obj
<<
/S /GoTo
/D [837 0 R /XYZ 0 792 null]
>>
endobj
1864 0 obj
<<
/S /GoTo
/D [877 0 R /XYZ 0 792 null]
>>
endobj
1865 0 obj
<<
/A 1866 0 R
/Count 0
/Next 1863 0 R
/Prev 1862 0 R
/Title (5.1.2 Management of Specific Adverse Events)
/Parent 1658 0 R
/F 0
/C [0 0 0]
>>
endobj
1862 0 obj
<<
/C [0 0 0]
/Parent 1658 0 R
/A 1867 0 R
/Last 1869 0 R
/First 1868 0 R
/Count 5
/Title (5.1.1 Risks Associated with Emicizumab)
/Next 1865 0 R
/F 0
>>
endobj
1863 0 obj
<<
/A 1864 0 R
/Count 0
/Prev 1865 0 R
/Title (5.1.3 Interpretation of Coagulation Assays for Patients Receiving Emicizumab)
/Parent 1658 0 R
/F 0
/C [0 0 0]
>>
endobj
1860 0 obj
<<
/S /GoTo
/D [1000 0 R /XYZ 0 792 null]
>>
endobj
1861 0 obj
<<
/S /GoTo
/D [837 0 R /XYZ 0 792 null]
>>
endobj
1858 0 obj
<<
/S /GoTo
/D [978 0 R /XYZ 0 792 null]
>>
endobj
1859 0 obj
<<
/S /GoTo
/D [1000 0 R /XYZ 0 792 null]
>>
endobj
1856 0 obj
<<
/S /GoTo
/D [978 0 R /XYZ 0 792 null]
>>
endobj
1857 0 obj
<<
/A 1858 0 R
/Count 0
/Title (Medical Monitor Contact Information for All Sites)
/Parent 1793 0 R
/F 0
/C [0 0 0]
>>
endobj
1918 0 obj
<<
/S /GoTo
/D [1047 0 R /XYZ 0 792 null]
>>
endobj
1919 0 obj
<<
/S /GoTo
/D [1047 0 R /XYZ 0 792 null]
>>
endobj
1916 0 obj
<<
/S /GoTo
/D [1054 0 R /XYZ 0 792 null]
>>
endobj
1917 0 obj
<<
/A 1918 0 R
/Count 0
/Next 1915 0 R
/Prev 1646 0 R
/Title (8.2 Informed Consent)
/Parent 1644 0 R
/F 0
/C [0 0 0]
>>
endobj
1914 0 obj
<<
/S /GoTo
/D [1054 0 R /XYZ 0 792 null]
>>
endobj
1915 0 obj
<<
/A 1916 0 R
/Count 0
/Next 1913 0 R
/Prev 1917 0 R
/Title (8.3 Institutional Review Board or Ethics Committee)
/Parent 1644 0 R
/F 0
/C [0 0 0]
>>
endobj
1912 0 obj
<<
/S /GoTo
/D [1059 0 R /XYZ 0 792 null]
>>
endobj
1913 0 obj
<<
/A 1914 0 R
/Count 0
/Next 1647 0 R
/Prev 1915 0 R
/Title (8.4 Confidentiality)
/Parent 1644 0 R
/F 0
/C [0 0 0]
>>
endobj
1910 0 obj
<<
/S /GoTo
/D [1037 0 R /XYZ 0 792 null]
>>
endobj
1911 0 obj
<<
/S /GoTo
/D [1037 0 R /XYZ 0 792 null]
>>
endobj
1908 0 obj
<<
/S /GoTo
/D [1037 0 R /XYZ 0 792 null]
>>
endobj
1909 0 obj
<<
/A 1910 0 R
/Count 0
/Next 1907 0 R
/Prev 1650 0 R
/Title (7.2 Electronic Case Report Forms)
/Parent 1648 0 R
/F 0
/C [0 0 0]
>>
endobj
1906 0 obj
<<
/S /GoTo
/D [1042 0 R /XYZ 0 792 null]
>>
endobj
1907 0 obj
<<
/A 1908 0 R
/Count 0
/Next 1905 0 R
/Prev 1909 0 R
/Title (7.3 Patient-Reported Outcome Data)
/Parent 1648 0 R
/F 0
/C [0 0 0]
>>
endobj
1904 0 obj
<<
/S /GoTo
/D [1042 0 R /XYZ 0 792 null]
>>
endobj
1905 0 obj
<<
/A 1906 0 R
/Count 0
/Next 1903 0 R
/Prev 1907 0 R
/Title (7.4 Source Data Documentation)
/Parent 1648 0 R
/F 0
/C [0 0 0]
>>
endobj
1902 0 obj
<<
/S /GoTo
/D [1047 0 R /XYZ 0 792 null]
>>
endobj
1903 0 obj
<<
/A 1904 0 R
/Count 0
/Next 1651 0 R
/Prev 1905 0 R
/Title (7.5 Use of Computerized Systems)
/Parent 1648 0 R
/F 0
/C [0 0 0]
>>
endobj
1900 0 obj
<<
/S /GoTo
/D [1030 0 R /XYZ 0 792 null]
>>
endobj
1901 0 obj
<<
/S /GoTo
/D [1009 0 R /XYZ 0 792 null]
>>
endobj
1898 0 obj
<<
/S /GoTo
/D [1030 0 R /XYZ 0 792 null]
>>
endobj
1899 0 obj
<<
/A 1900 0 R
/Count 0
/Title (6.9.1.1 JMC Recommendations and Enrollment of Q2W/Q4W in Pediatric Patients)
/Parent 1879 0 R
/F 0
/C [0 0 0]
>>
endobj
1896 0 obj
<<
/S /GoTo
/D [1019 0 R /XYZ 0 792 null]
>>
endobj
1897 0 obj
<<
/S /GoTo
/D [1014 0 R /XYZ 0 792 null]
>>
endobj
1894 0 obj
<<
/A 1895 0 R
/Count 0
/Next 1892 0 R
/Prev 1654 0 R
/Title (6.2 Summaries of Conduct of Study)
/Parent 1652 0 R
/F 0
/C [0 0 0]
>>
endobj
1895 0 obj
<<
/S /GoTo
/D [1014 0 R /XYZ 0 792 null]
>>
endobj
1892 0 obj
<<
/A 1893 0 R
/Count 0
/Next 1888 0 R
/Prev 1894 0 R
/Title (6.3 Summaries of Demographic and Baseline Characteristics)
/Parent 1652 0 R
/F 0
/C [0 0 0]
>>
endobj
1893 0 obj
<<
/S /GoTo
/D [1014 0 R /XYZ 0 792 null]
>>
endobj
1890 0 obj
<<
/A 1897 0 R
/Count 0
/Next 1891 0 R
/Title (6.4.1 Efficacy Endpoints)
/Parent 1888 0 R
/F 0
/C [0 0 0]
>>
endobj
1891 0 obj
<<
/A 1896 0 R
/Count 0
/Prev 1890 0 R
/Title (6.4.2 Exploratory Efficacy Endpoints)
/Parent 1888 0 R
/F 0
/C [0 0 0]
>>
endobj
1888 0 obj
<<
/C [0 0 0]
/Parent 1652 0 R
/A 1889 0 R
/Last 1891 0 R
/First 1890 0 R
/Count 2
/Title (6.4 Efficacy Analyses)
/Prev 1892 0 R
/Next 1886 0 R
/F 0
>>
endobj
1889 0 obj
<<
/S /GoTo
/D [1014 0 R /XYZ 0 792 null]
>>
endobj
1694 0 obj
<<
/A 1695 0 R
/Count 0
/Next 1692 0 R
/Prev 1696 0 R
/Title (Nonclinical Studies)
/Parent 1689 0 R
/F 0
/C [0 0 0]
>>
endobj
1695 0 obj
<<
/S /GoTo
/D [531 0 R /XYZ 0 792 null]
>>
endobj
1692 0 obj
<<
/A 1693 0 R
/Count 0
/Prev 1694 0 R
/Title (Clinical Studies)
/Parent 1689 0 R
/F 0
/C [0 0 0]
>>
endobj
1693 0 obj
<<
/S /GoTo
/D [538 0 R /XYZ 0 792 null]
>>
endobj
1690 0 obj
<<
/S /GoTo
/D [518 0 R /XYZ 0 792 null]
>>
endobj
1691 0 obj
<<
/A 1698 0 R
/Count 0
/Next 1696 0 R
/Title (Description of the Molecule)
/Parent 1689 0 R
/F 0
/C [0 0 0]
>>
endobj
1688 0 obj
<<
/S /GoTo
/D [549 0 R /XYZ 0 792 null]
>>
endobj
1689 0 obj
<<
/C [0 0 0]
/Parent 1672 0 R
/A 1690 0 R
/Last 1692 0 R
/First 1691 0 R
/Count 4
/Title (1.2 Background on Emicizumab)
/Prev 1674 0 R
/Next 1675 0 R
/F 0
>>
endobj
1686 0 obj
<<
/S /GoTo
/D [26 0 R /XYZ 0 792 null]
>>
endobj
1687 0 obj
<<
/S /GoTo
/D [22 0 R /XYZ 0 792 null]
>>
endobj
1684 0 obj
<<
/A 1687 0 R
/Count 0
/Next 1685 0 R
/Title (Rationale)
/Parent 1682 0 R
/F 0
/C [0 0 0]
>>
endobj
1685 0 obj
<<
/A 1686 0 R
/Count 0
/Prev 1684 0 R
/Title (Summary of Changes)
/Parent 1682 0 R
/F 0
/C [0 0 0]
>>
endobj
1682 0 obj
<<
/C [0 0 0]
/Parent 1623 0 R
/A 1683 0 R
/Last 1685 0 R
/First 1684 0 R
/Count 2
/Title (Protocol Amendment, Version 4\r)
/Prev 1625 0 R
/Next 1680 0 R
/F 0
>>
endobj
1683 0 obj
<<
/S /GoTo
/D [22 0 R /XYZ 0 792 null]
>>
endobj
1680 0 obj
<<
/A 1681 0 R
/Count 0
/Next 1678 0 R
/Prev 1682 0 R
/Title (Protocol Amendment Acceptance Form)
/Parent 1623 0 R
/F 0
/C [0 0 0]
>>
endobj
1681 0 obj
<<
/S /GoTo
/D [380 0 R /XYZ 0 792 null]
>>
endobj
1678 0 obj
<<
/A 1679 0 R
/Count 0
/Next 1676 0 R
/Prev 1680 0 R
/Title (Protocol Synopsis)
/Parent 1623 0 R
/F 0
/C [0 0 0]
>>
endobj
1679 0 obj
<<
/S /GoTo
/D [383 0 R /XYZ 0 792 null]
>>
endobj
1676 0 obj
<<
/A 1677 0 R
/Count 0
/Next 1672 0 R
/Prev 1678 0 R
/Title (List of Abbreviations and Definitions of Terms\r)
/Parent 1623 0 R
/F 0
/C [0 0 0]
>>
endobj
1677 0 obj
<<
/S /GoTo
/D [401 0 R /XYZ 0 792 null]
>>
endobj
1674 0 obj
<<
/A 1699 0 R
/Count 0
/Next 1689 0 R
/Title (1.1 Background on Pediatric Hemophilia A with Inhibitors)
/Parent 1672 0 R
/F 0
/C [0 0 0]
>>
endobj
1675 0 obj
<<
/A 1688 0 R
/Count 0
/Prev 1689 0 R
/Title (1.3 Study Rationale and BenefitRisk Assessment)
/Parent 1672 0 R
/F 0
/C [0 0 0]
>>
endobj
1672 0 obj
<<
/C [0 0 0]
/Parent 1623 0 R
/A 1673 0 R
/Last 1675 0 R
/First 1674 0 R
/Count 7
/Title (1. Background)
/Prev 1676 0 R
/Next 1668 0 R
/F 0
>>
endobj
1673 0 obj
<<
/S /GoTo
/D [405 0 R /XYZ 0 792 null]
>>
endobj
1670 0 obj
<<
/A 1705 0 R
/Count 0
/Next 1703 0 R
/Title (2.1 Efficacy Objectives)
/Parent 1668 0 R
/F 0
/C [0 0 0]
>>
endobj
1671 0 obj
<<
/A 1700 0 R
/Count 0
/Prev 1701 0 R
/Title (2.4 Pharmacodynamic Biomarker Objective)
/Parent 1668 0 R
/F 0
/C [0 0 0]
>>
endobj
1668 0 obj
<<
/C [0 0 0]
/Parent 1623 0 R
/A 1669 0 R
/Last 1671 0 R
/First 1670 0 R
/Count 4
/Title (2. Objectives and Endpoints)
/Prev 1672 0 R
/Next 1664 0 R
/F 0
>>
endobj
1669 0 obj
<<
/S /GoTo
/D [582 0 R /XYZ 0 792 null]
>>
endobj
1666 0 obj
<<
/A 1727 0 R
/Count 0
/Next 1709 0 R
/Title (3.1 Description of the Study)
/Parent 1664 0 R
/F 0
/C [0 0 0]
>>
endobj
1667 0 obj
<<
/C [0 0 0]
/Parent 1664 0 R
/A 1706 0 R
/Last 1708 0 R
/First 1707 0 R
/Count 7
/Title (3.3 Rationale for Study Design)
/Prev 1709 0 R
/F 0
>>
endobj
1664 0 obj
<<
/C [0 0 0]
/Parent 1623 0 R
/A 1665 0 R
/Last 1667 0 R
/First 1666 0 R
/Count 12
/Title (3. Study Design)
/Prev 1668 0 R
/Next 1660 0 R
/F 0
>>
endobj
1665 0 obj
<<
/S /GoTo
/D [595 0 R /XYZ 0 792 null]
>>
endobj
1726 0 obj
<<
/S /GoTo
/D [707 0 R /XYZ 0 792 null]
>>
endobj
1727 0 obj
<<
/S /GoTo
/D [595 0 R /XYZ 0 792 null]
>>
endobj
1724 0 obj
<<
/S /GoTo
/D [667 0 R /XYZ 0 792 null]
>>
endobj
1725 0 obj
<<
/A 1726 0 R
/Count 0
/Title (3.3.1.1 Interim Analysis, JMC Recommendations, and Rationale for Enrollment of Q2W/Q4W in Pediatric Patients)
/Parent 1707 0 R
/F 0
/C [0 0 0]
>>
endobj
1722 0 obj
<<
/A 1723 0 R
/Count 0
/Next 1720 0 R
/Prev 1707 0 R
/Title (3.3.2 Rationale for Patient Population)
/Parent 1667 0 R
/F 0
/C [0 0 0]
>>
endobj
1723 0 obj
<<
/S /GoTo
/D [720 0 R /XYZ 0 792 null]
>>
endobj
1720 0 obj
<<
/A 1721 0 R
/Count 0
/Next 1718 0 R
/Prev 1722 0 R
/Title (3.3.3 Rationale for the Efficacy Analyses)
/Parent 1667 0 R
/F 0
/C [0 0 0]
>>
endobj
1721 0 obj
<<
/S /GoTo
/D [725 0 R /XYZ 0 792 null]
>>
endobj
1718 0 obj
<<
/A 1719 0 R
/Count 0
/Next 1716 0 R
/Prev 1720 0 R
/Title (3.3.4 Rationale for Patient-Reported Outcome Assessments)
/Parent 1667 0 R
/F 0
/C [0 0 0]
>>
endobj
1719 0 obj
<<
/S /GoTo
/D [732 0 R /XYZ 0 792 null]
>>
endobj
1716 0 obj
<<
/A 1717 0 R
/Count 0
/Next 1708 0 R
/Prev 1718 0 R
/Title (3.3.5 Rationale for Biomarker Assessments)
/Parent 1667 0 R
/F 0
/C [0 0 0]
>>
endobj
1717 0 obj
<<
/S /GoTo
/D [745 0 R /XYZ 0 792 null]
>>
endobj
1714 0 obj
<<
/S /GoTo
/D [637 0 R /XYZ 0 792 null]
>>
endobj
1715 0 obj
<<
/S /GoTo
/D [752 0 R /XYZ 0 792 null]
>>
endobj
1712 0 obj
<<
/A 1713 0 R
/Count 0
/Prev 1711 0 R
/Title (End of Study\r)
/Parent 1709 0 R
/F 0
/C [0 0 0]
>>
endobj
1713 0 obj
<<
/S /GoTo
/D [637 0 R /XYZ 0 792 null]
>>
endobj
1710 0 obj
<<
/S /GoTo
/D [637 0 R /XYZ 0 792 null]
>>
endobj
1711 0 obj
<<
/A 1714 0 R
/Count 0
/Next 1712 0 R
/Title (Length of Study\r)
/Parent 1709 0 R
/F 0
/C [0 0 0]
>>
endobj
1708 0 obj
<<
/A 1715 0 R
/Count 0
/Prev 1716 0 R
/Title (3.3.6 Rationale for Pharmacokinetic Sample Schedule)
/Parent 1667 0 R
/F 0
/C [0 0 0]
>>
endobj
1709 0 obj
<<
/C [0 0 0]
/Parent 1664 0 R
/A 1710 0 R
/Last 1712 0 R
/First 1711 0 R
/Count 2
/Title (3.2 End of Study and Length of Study)
/Prev 1666 0 R
/Next 1667 0 R
/F 0
>>
endobj
1706 0 obj
<<
/S /GoTo
/D [652 0 R /XYZ 0 792 null]
>>
endobj
1707 0 obj
<<
/C [0 0 0]
/Parent 1667 0 R
/A 1724 0 R
/Last 1725 0 R
/First 1725 0 R
/Count 1
/Title (3.3.1 Rationale for Emicizumab Dose and Schedule)
/Next 1722 0 R
/F 0
>>
endobj
1704 0 obj
<<
/S /GoTo
/D [593 0 R /XYZ 0 792 null]
>>
endobj
1705 0 obj
<<
/S /GoTo
/D [582 0 R /XYZ 0 792 null]
>>
endobj
1702 0 obj
<<
/S /GoTo
/D [595 0 R /XYZ 0 792 null]
>>
endobj
1703 0 obj
<<
/A 1704 0 R
/Count 0
/Next 1701 0 R
/Prev 1670 0 R
/Title (2.2 Safety Objective)
/Parent 1668 0 R
/F 0
/C [0 0 0]
>>
endobj
1700 0 obj
<<
/S /GoTo
/D [595 0 R /XYZ 0 792 null]
>>
endobj
1701 0 obj
<<
/A 1702 0 R
/Count 0
/Next 1671 0 R
/Prev 1703 0 R
/Title (2.3 Pharmacokinetic Objective)
/Parent 1668 0 R
/F 0
/C [0 0 0]
>>
endobj
1698 0 obj
<<
/S /GoTo
/D [518 0 R /XYZ 0 792 null]
>>
endobj
1699 0 obj
<<
/S /GoTo
/D [405 0 R /XYZ 0 792 null]
>>
endobj
1696 0 obj
<<
/A 1697 0 R
/Count 0
/Next 1694 0 R
/Prev 1691 0 R
/Title (Mechanism of Action)
/Parent 1689 0 R
/F 0
/C [0 0 0]
>>
endobj
1697 0 obj
<<
/S /GoTo
/D [518 0 R /XYZ 0 792 null]
>>
endobj
1758 0 obj
<<
/S /GoTo
/D [780 0 R /XYZ 0 792 null]
>>
endobj
1759 0 obj
<<
/S /GoTo
/D [811 0 R /XYZ 0 792 null]
>>
endobj
1756 0 obj
<<
/S /GoTo
/D [761 0 R /XYZ 0 792 null]
>>
endobj
1757 0 obj
<<
/S /GoTo
/D [787 0 R /XYZ 0 792 null]
>>
endobj
1754 0 obj
<<
/S /GoTo
/D [761 0 R /XYZ 0 792 null]
>>
endobj
1755 0 obj
<<
/A 1756 0 R
/Count 0
/Title (4.5.1.1 Emicizumab)
/Parent 1741 0 R
/F 0
/C [0 0 0]
>>
endobj
1752 0 obj
<<
/A 1753 0 R
/Count 0
/Next 1750 0 R
/Prev 1741 0 R
/Title (4.5.2 Dosage, Administration, and Compliance)
/Parent 1739 0 R
/F 0
/C [0 0 0]
>>
endobj
1753 0 obj
<<
/S /GoTo
/D [761 0 R /XYZ 0 792 null]
>>
endobj
1750 0 obj
<<
/A 1751 0 R
/Count 0
/Next 1742 0 R
/Prev 1752 0 R
/Title (4.5.3 Investigational Medicinal Product Accountability)
/Parent 1739 0 R
/F 0
/C [0 0 0]
>>
endobj
1751 0 obj
<<
/S /GoTo
/D [773 0 R /XYZ 0 792 null]
>>
endobj
1748 0 obj
<<
/S /GoTo
/D [752 0 R /XYZ 0 792 null]
>>
endobj
1749 0 obj
<<
/S /GoTo
/D [778 0 R /XYZ 0 792 null]
>>
endobj
1746 0 obj
<<
/S /GoTo
/D [757 0 R /XYZ 0 792 null]
>>
endobj
1747 0 obj
<<
/A 1748 0 R
/Count 0
/Next 1745 0 R
/Prev 1662 0 R
/Title (4.2 Inclusion Criteria)
/Parent 1660 0 R
/F 0
/C [0 0 0]
>>
endobj
1744 0 obj
<<
/S /GoTo
/D [759 0 R /XYZ 0 792 null]
>>
endobj
1745 0 obj
<<
/A 1746 0 R
/Count 0
/Next 1743 0 R
/Prev 1747 0 R
/Title (4.3 Exclusion Criteria)
/Parent 1660 0 R
/F 0
/C [0 0 0]
>>
endobj
1742 0 obj
<<
/A 1749 0 R
/Count 0
/Prev 1750 0 R
/Title (4.5.4 Post-Study Access to Emicizumab)
/Parent 1739 0 R
/F 0
/C [0 0 0]
>>
endobj
1743 0 obj
<<
/A 1744 0 R
/Count 0
/Next 1739 0 R
/Prev 1745 0 R
/Title (4.4 Method of Treatment Assignment)
/Parent 1660 0 R
/F 0
/C [0 0 0]
>>
endobj
1740 0 obj
<<
/S /GoTo
/D [761 0 R /XYZ 0 792 null]
>>
endobj
1741 0 obj
<<
/C [0 0 0]
/Parent 1739 0 R
/A 1754 0 R
/Last 1755 0 R
/First 1755 0 R
/Count 1
/Title (4.5.1 Formulation, Packaging, and Handling)
/Next 1752 0 R
/F 0
>>
endobj
1738 0 obj
<<
/A 1757 0 R
/Count 0
/Prev 1737 0 R
/Title (4.6.2 Prohibited Therapy)
/Parent 1735 0 R
/F 0
/C [0 0 0]
>>
endobj
1739 0 obj
<<
/C [0 0 0]
/Parent 1660 0 R
/A 1740 0 R
/Last 1742 0 R
/First 1741 0 R
/Count 5
/Title (4.5 Study Treatment)
/Prev 1743 0 R
/Next 1735 0 R
/F 0
>>
endobj
1736 0 obj
<<
/S /GoTo
/D [780 0 R /XYZ 0 792 null]
>>
endobj
1737 0 obj
<<
/A 1758 0 R
/Count 0
/Next 1738 0 R
/Title (4.6.1 Permitted Therapy)
/Parent 1735 0 R
/F 0
/C [0 0 0]
>>
endobj
1734 0 obj
<<
/C [0 0 0]
/Parent 1731 0 R
/A 1759 0 R
/Last 1761 0 R
/First 1760 0 R
/Count 3
/Title (4.7.8 Bleed Definitions)
/Prev 1762 0 R
/F 0
>>
endobj
1735 0 obj
<<
/C [0 0 0]
/Parent 1660 0 R
/A 1736 0 R
/Last 1738 0 R
/First 1737 0 R
/Count 2
/Title (4.6 Concomitant and Rescue Therapy)
/Prev 1739 0 R
/Next 1731 0 R
/F 0
>>
endobj
1732 0 obj
<<
/S /GoTo
/D [787 0 R /XYZ 0 792 null]
>>
endobj
1733 0 obj
<<
/A 1778 0 R
/Count 0
/Next 1772 0 R
/Title (4.7.1 Informed Consent Forms and Screening Log)
/Parent 1731 0 R
/F 0
/C [0 0 0]
>>
endobj
1730 0 obj
<<
/A 1779 0 R
/Count 0
/Prev 1780 0 R
/Title (4.8.3 Study and Site Discontinuation)
/Parent 1663 0 R
/F 0
/C [0 0 0]
>>
endobj
1731 0 obj
<<
/C [0 0 0]
/Parent 1660 0 R
/A 1732 0 R
/Last 1734 0 R
/First 1733 0 R
/Count 11
/Title (4.7 Study Assessments)
/Prev 1735 0 R
/Next 1663 0 R
/F 0
>>
endobj
1728 0 obj
<<
/S /GoTo
/D [835 0 R /XYZ 0 792 null]
>>
endobj
1729 0 obj
<<
/A 1782 0 R
/Count 0
/Next 1780 0 R
/Title (4.8.1 Patient Discontinuation)
/Parent 1663 0 R
/F 0
/C [0 0 0]
>>
endobj
1790 0 obj
<<
/A 1859 0 R
/Count 0
/Prev 1789 0 R
/Title (5.5.2 Sponsor Follow-Up)
/Parent 1787 0 R
/F 0
/C [0 0 0]
>>
endobj
1791 0 obj
<<
/C [0 0 0]
/Parent 1656 0 R
/A 1792 0 R
/Last 1794 0 R
/First 1793 0 R
/Count 10
/Title (5.4 Immediate Reporting Requirements from Investigator to Sponsor)
/Prev 1795 0 R
/Next 1787 0 R
/F 0
>>
endobj
1788 0 obj
<<
/S /GoTo
/D [1000 0 R /XYZ 0 792 null]
>>
endobj
1789 0 obj
<<
/A 1860 0 R
/Count 0
/Next 1790 0 R
/Title (5.5.1 Investigator Follow-Up)
/Parent 1787 0 R
/F 0
/C [0 0 0]
>>
endobj
1786 0 obj
<<
/S /GoTo
/D [1000 0 R /XYZ 0 792 null]
>>
endobj
1787 0 obj
<<
/C [0 0 0]
/Parent 1656 0 R
/A 1788 0 R
/Last 1790 0 R
/First 1789 0 R
/Count 2
/Title (5.5 Follow-Up of Patients after Adverse Events)
/Prev 1791 0 R
/Next 1785 0 R
/F 0
>>
endobj
1784 0 obj
<<
/S /GoTo
/D [1009 0 R /XYZ 0 792 null]
>>
endobj
1785 0 obj
<<
/A 1786 0 R
/Count 0
/Next 1659 0 R
/Prev 1787 0 R
/Title (5.6 Post-Study Adverse Events)
/Parent 1656 0 R
/F 0
/C [0 0 0]
>>
endobj
1782 0 obj
<<
/S /GoTo
/D [835 0 R /XYZ 0 792 null]
>>
endobj
1783 0 obj
<<
/S /GoTo
/D [752 0 R /XYZ 0 792 null]
>>
endobj
1780 0 obj
<<
/A 1781 0 R
/Count 0
/Next 1730 0 R
/Prev 1729 0 R
/Title (4.8.2 Study Treatment Discontinuation)
/Parent 1663 0 R
/F 0
/C [0 0 0]
>>
endobj
1781 0 obj
<<
/S /GoTo
/D [835 0 R /XYZ 0 792 null]
>>
endobj
1778 0 obj
<<
/S /GoTo
/D [787 0 R /XYZ 0 792 null]
>>
endobj
1779 0 obj
<<
/S /GoTo
/D [837 0 R /XYZ 0 792 null]
>>
endobj
1776 0 obj
<<
/S /GoTo
/D [828 0 R /XYZ 0 792 null]
>>
endobj
1777 0 obj
<<
/S /GoTo
/D [811 0 R /XYZ 0 792 null]
>>
endobj
1774 0 obj
<<
/S /GoTo
/D [828 0 R /XYZ 0 792 null]
>>
endobj
1775 0 obj
<<
/A 1776 0 R
/Count 0
/Next 1761 0 R
/Prev 1760 0 R
/Title (Definitions of Bleed Sites)
/Parent 1734 0 R
/F 0
/C [0 0 0]
>>
endobj
1772 0 obj
<<
/A 1773 0 R
/Count 0
/Next 1770 0 R
/Prev 1733 0 R
/Title (4.7.2 Medical History and Demographic Data)
/Parent 1731 0 R
/F 0
/C [0 0 0]
>>
endobj
1773 0 obj
<<
/S /GoTo
/D [789 0 R /XYZ 0 792 null]
>>
endobj
1770 0 obj
<<
/A 1771 0 R
/Count 0
/Next 1768 0 R
/Prev 1772 0 R
/Title (4.7.3 Physical Examinations)
/Parent 1731 0 R
/F 0
/C [0 0 0]
>>
endobj
1771 0 obj
<<
/S /GoTo
/D [789 0 R /XYZ 0 792 null]
>>
endobj
1768 0 obj
<<
/A 1769 0 R
/Count 0
/Next 1766 0 R
/Prev 1770 0 R
/Title (4.7.4 Vital Signs)
/Parent 1731 0 R
/F 0
/C [0 0 0]
>>
endobj
1769 0 obj
<<
/S /GoTo
/D [789 0 R /XYZ 0 792 null]
>>
endobj
1766 0 obj
<<
/A 1767 0 R
/Count 0
/Next 1764 0 R
/Prev 1768 0 R
/Title (4.7.5 Laboratory, Biomarker, and Other Biological Samples)
/Parent 1731 0 R
/F 0
/C [0 0 0]
>>
endobj
1767 0 obj
<<
/S /GoTo
/D [789 0 R /XYZ 0 792 null]
>>
endobj
1764 0 obj
<<
/A 1765 0 R
/Count 0
/Next 1762 0 R
/Prev 1766 0 R
/Title (4.7.6 Electrocardiograms)
/Parent 1731 0 R
/F 0
/C [0 0 0]
>>
endobj
1765 0 obj
<<
/S /GoTo
/D [802 0 R /XYZ 0 792 null]
>>
endobj
1762 0 obj
<<
/A 1763 0 R
/Count 0
/Next 1734 0 R
/Prev 1764 0 R
/Title (4.7.7 Electronic Patient-Reported Outcomes)
/Parent 1731 0 R
/F 0
/C [0 0 0]
>>
endobj
1763 0 obj
<<
/S /GoTo
/D [802 0 R /XYZ 0 792 null]
>>
endobj
1760 0 obj
<<
/A 1777 0 R
/Count 0
/Next 1775 0 R
/Title (Definition of a Bleed)
/Parent 1734 0 R
/F 0
/C [0 0 0]
>>
endobj
1761 0 obj
<<
/A 1774 0 R
/Count 0
/Prev 1775 0 R
/Title (Definitions of Bleed Types)
/Parent 1734 0 R
/F 0
/C [0 0 0]
>>
endobj
1566 0 obj
<<
/Nums [0 [1568 0 R 1569 0 R 1570 0 R 1571 0 R 1572 0 R 1573 0 R 1574 0 R 1575 0 R 1576 0 R 1577 0 R 1578 0 R 1579 0 R]]
>>
endobj
1567 0 obj
<<
/Diagram /Figure
/InlineShape /Figure
/Annotation /Span
/Endnote /Note
/Underline /Span
/Superscript /Span
/Footnote /Note
/Chart /Figure
/TextBox /Art
/Bibliography /BibEntry
/Artifact /P
/Outline /Span
/Strikeout /Span
/Subscript /Span
/DropCap /Figure
>>
endobj
1564 0 obj
<<
/ParentTree 1566 0 R
/K 1565 0 R
/Type /StructTreeRoot
/ParentTreeNextKey 1
/RoleMap 1567 0 R
>>
endobj
1565 0 obj
<<
/K [1582 0 R 1568 0 R 1569 0 R]
/Type /StructElem
/S /Sect
/P 1564 0 R
>>
endobj
1560 0 obj
<<
/Type /Font
/DescendantFonts [1138 0 R]
/BaseFont /CPWYUD+TimesNewRoman
/Encoding /Identity-H
/Subtype /Type0
/ToUnicode 1139 0 R
>>
endobj
1558 0 obj
<<
/Matrix [1.0 0 0 1.0 -89.8281 -74.766]
/Type /XObject
/Filter /FlateDecode
/BBox [89.828 74.766 552.29 694.32]
/Length 81
/FormType 1
/Subtype /Form
/Resources <<
>>
>>
stream
H2P*2PH*T0T0 BCK=c#CsS=#33\.x.%gZ虚EP 5i\@` <
endstream
endobj
1559 0 obj
<<
/Matrix [1.0 0 0 1.0 -85.9008 -67.8932]
/Type /XObject
/Filter /FlateDecode
/BBox [85.901 67.893 547.38 682.53]
/Length 82
/FormType 1
/Subtype /Form
/Resources <<
>>
>>
stream
H2P*2PH*T0T0 BC3=3=cKc#\.D.9g뙙EP 5i\@` ކj
endstream
endobj
1556 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 50.058 13.675]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1557 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 22.215 11.966]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1554 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 24.501 27.35]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1555 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 22.215 11.966]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1552 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 15.378 27.35]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1553 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 24.501 27.35]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1550 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 15.378 27.35]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1551 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 106.7 19.726]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1548 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 33.24 27.35]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1549 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 33.24 27.35]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1546 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 95.541 27.35]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1547 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 15.26 15.385]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1544 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 15.26 26.496]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1545 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 24.501 14.53]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1542 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 24.501 27.35]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1543 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 24.501 14.53]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1540 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 24.501 27.35]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1541 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 24.501 14.53]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1538 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 15.378 27.35]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1539 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 103.93 14.53]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1536 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 24.381 18.803]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1537 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 15.26 14.53]
/Length 10
/Subtype /Form
/Resources <<
>>
>>
stream
H0
endstream
endobj
1598 0 obj
<<
/Filter /FlateDecode
/Length 2574
/Range [0 1.0 0 1.0 0 1.0]
/N 3
>>
stream
HyTSwoɞc
[5laQIBHADED2mtFOE.c}088GNg9w߽ '0 ֠Jb
2y.-;!KZ ^i"L0-
@8(r;q7Ly&Qq4j|9
V)gB0iW8#8wթ8_٥ʨQQj@&A)/g>'K t;\
ӥ$պFZUn(4T%)뫔0C&Zi8bxEB;Pӓ̹Aom?W=
x- [ 0}y)7ta>jT7@tܛ`q2ʀ&6ZLĄ?_yxg)˔zçLU*uSkSeO4?c. R
߁-25 S>ӣVd`rn~Y&+`;A4 A9 =-tl`;~p Gp| [`L`< "AYA+Cb(R, *T2B-
ꇆnQt}MA0alSx k&^>0|>_',G!"F$H:R!zFQd?r9\A&GrQhE]a4zBgE#H *B=0HIpp0MxJ$D1D, VĭKĻYdE"EI2EBGt4MzNr!YK ?%_(0J:EAiQ(()ӔWT6U@P+!~mDeԴ!hӦh/']B/ҏӿ?a0nhF!X8܌kc&5S6lIa2cKMA!E#ƒdV(kel
}}Cq9
N')].uJr
wG xR^[oƜchg`>b$*~ :Eb~,m,-ݖ,Y¬*6X[ݱF=3뭷Y~dó tizf6~`{v.Ng#{}}jc1X6fm;'_9 r:8q:˜O:ϸ8uJqnv=MmR 4
n3ܣkGݯz=[==<=GTB(/S,]6*-W:#7*e^YDY}UjAyT`#D="b{ų+ʯ:!kJ4Gmt}uC%K7YVfFY.=b?SƕƩȺy
چk5%4m7lqlioZlG+Zzmzy]?uuw|"űNwW&e֥ﺱ*|j5kyݭǯg^ykEklD_p߶7Dmo꿻1ml{Mś
nLl<9O [$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD- u`ֲK³8%yhYѹJº;.!
zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs
2F[p(@Xr4Pm8Ww)Km
endstream
endobj
1599 0 obj
<<
/Subject ()
/CreationDate (D:20170901075956+02'00')
/Producer (Amyuni PDF Converter version 4.5.3.7; modified using iText 2.1.7 by 1T3XT)
/Creator (C2 v4.5.0130 build 636 - c2_rendition_config : Signature Page Protocol)
/Title ()
/ModDate (D:20190320092934-04'00')
/Keywords ()
>>
endobj
1596 0 obj
<<
/Type /Metadata
/Length 4739
/Subtype /XML
>>
stream
2017-09-01T07:59:56+02:00C2 v4.5.0130 build 636 - c2_rendition_config : Signature Page Protocol2019-03-20T09:29:34-04:00Amyuni PDF Converter version 4.5.3.7; modified using iText 2.1.7 by 1T3XTapplication/pdfuuid:81633c3e-7f5c-4db5-a0d8-137414ce538auuid:0d937843-a8e6-46dc-99fe-8522c94608f6default1converteduuid:2bfcf1b4-340c-4c5f-bc26-3d2724ee8ac7converted to PDF/A-1bPreflight2019-02-27T11:10:16-05:00http://ns.adobe.com/pdf/1.3/pdfAdobe PDF SchemainternalA name object indicating whether the document has been modified to include trapping informationTrappedTexthttp://ns.adobe.com/xap/1.0/mm/xmpMMXMP Media Management SchemainternalUUID based identifier for specific incarnation of a documentInstanceIDURIinternalThe common identifier for all versions and renditions of a document.OriginalDocumentIDURIhttp://www.aiim.org/pdfa/ns/id/pdfaidPDF/A ID SchemainternalPart of PDF/A standardpartIntegerinternalAmendment of PDF/A standardamdTextinternalConformance level of PDF/A standardconformanceText
endstream
endobj
1597 0 obj
[<<
/RegistryName ()
/Type /OutputIntent
/OutputConditionIdentifier (Custom)
/S /GTS_PDFA1
/Info (sRGB IEC61966-2.1)
/DestOutputProfile 1598 0 R
/OutputCondition (sRGB)
>>]
endobj
1594 0 obj
<<
/Names [( ~ i c o n + C o m m e n t + 2 5 5 : 2 5 5 : 0 - E N U - 0) 1595 0 R]
>>
endobj
1595 0 obj
<<
/Type /XObject
/Filter /FlateDecode
/BBox [0 0 18.0 18.0]
/Length 294
/Subtype /Form
/Resources <<
/ExtGState <<
/GS0 <<
/AIS false
/ca 0.6
/Type /ExtGState
/CA 0.6
/BM /Normal
>>
>>
>>
>>
stream
HMN0.Pc=HH,KĆ Xp}^'@jg&b|!_NÍΪr
hьzFaNE1)fRȲ",yeog/s)BŞN:ᄊ'. nn֩Dս}am
֟
U12qʷ̽u,KdR"CB+:n>kCu %J21dXfqmig& Z=+5VQg!ӲAWǧ !l
endstream
endobj
1592 0 obj
<<
/Kids [1604 0 R 1 0 R 22 0 R 24 0 R 26 0 R 28 0 R]
/Count 6
/Type /Pages
/Parent 1591 0 R
/ITXT (2.1.7)
>>
endobj
1593 0 obj
<<
/Kids [30 0 R 32 0 R 34 0 R 36 0 R 38 0 R 40 0 R 42 0 R 44 0 R 46 0 R 48 0 R 50 0 R 54 0 R 58 0 R 60 0 R 64 0 R
66 0 R 68 0 R 70 0 R 127 0 R 188 0 R 243 0 R 302 0 R 355 0 R 380 0 R 383 0 R 385 0 R 387 0 R 389 0 R 391 0 R 393 0 R 395 0 R
397 0 R 399 0 R 401 0 R 403 0 R 405 0 R 430 0 R 487 0 R 518 0 R 531 0 R 538 0 R 540 0 R 547 0 R 549 0 R 562 0 R 582 0 R 593 0 R
595 0 R 604 0 R 613 0 R 624 0 R 637 0 R 652 0 R 667 0 R 681 0 R 694 0 R 707 0 R 720 0 R 725 0 R 732 0 R 745 0 R 752 0 R 757 0 R
759 0 R 761 0 R 766 0 R 768 0 R 773 0 R 778 0 R 780 0 R 787 0 R 789 0 R 800 0 R 802 0 R 811 0 R 828 0 R 835 0 R 837 0 R 839 0 R
853 0 R 860 0 R 870 0 R 877 0 R 884 0 R 893 0 R 900 0 R 923 0 R 936 0 R 941 0 R 946 0 R 953 0 R 966 0 R 971 0 R 978 0 R 991 0 R
1000 0 R 1009 0 R 1014 0 R 1019 0 R 1025 0 R 1030 0 R 1037 0 R 1042 0 R 1047 0 R 1052 0 R 1054 0 R 1059 0 R 1061 0 R 1068 0 R 1070 0 R 1072 0 R
1074 0 R 1076 0 R 1078 0 R 1080 0 R 1082 0 R 1084 0 R 1086 0 R 1088 0 R 1093 0 R 1095 0 R 1100 0 R 1105 0 R 1107 0 R 1110 0 R 1112 0 R 1114 0 R
1116 0 R 1118 0 R 1120 0 R 1122 0 R 1124 0 R 1126 0 R 1128 0 R 1130 0 R 1132 0 R 1140 0 R 1142 0 R]
/Count 138
/Type /Pages
/Parent 1591 0 R
/ITXT (2.1.7)
>>
endobj
1590 0 obj
<<
/K [1575 0 R 1576 0 R]
/Type /StructElem
/S /TD
/P 1581 0 R
>>
endobj
1591 0 obj
<<
/Kids [1592 0 R 1593 0 R]
/Count 144
/Type /Pages
/ITXT (2.1.7)
>>
endobj
1588 0 obj
<<
/K [1570 0 R 1571 0 R]
/Type /StructElem
/S /TD
/P 1584 0 R
>>
endobj
1589 0 obj
<<
/K 1572 0 R
/Type /StructElem
/S /TD
/P 1584 0 R
>>
endobj
1586 0 obj
<<
/K 1573 0 R
/Type /StructElem
/S /TD
/P 1585 0 R
>>
endobj
1587 0 obj
<<
/K 1574 0 R
/Type /StructElem
/S /TD
/P 1585 0 R
>>
endobj
1584 0 obj
<<
/K [1588 0 R 1589 0 R]
/Type /StructElem
/S /TR
/P 1582 0 R
>>
endobj
1585 0 obj
<<
/K [1586 0 R 1587 0 R]
/Type /StructElem
/S /TR
/P 1582 0 R
>>
endobj
1582 0 obj
<<
/A 1583 0 R
/K [1584 0 R 1585 0 R 1581 0 R]
/Type /StructElem
/S /Table
/P 1565 0 R
>>
endobj
1583 0 obj
<<
/BBox [96.83 518.21 535.2 691.1]
/Placement /Block
/O /Layout
>>
endobj
1580 0 obj
<<
/K [1577 0 R 1578 0 R 1579 0 R]
/Type /StructElem
/S /TD
/P 1581 0 R
>>
endobj
1581 0 obj
<<
/K [1590 0 R 1580 0 R]
/Type /StructElem
/S /TR
/P 1582 0 R
>>
endobj
1578 0 obj
<<
/Pg 1604 0 R
/K 10
/Type /StructElem
/S /P
/P 1580 0 R
>>
endobj
1579 0 obj
<<
/Pg 1604 0 R
/K 11
/Type /StructElem
/S /P
/P 1580 0 R
>>
endobj
1576 0 obj
<<
/Pg 1604 0 R
/K 8
/Type /StructElem
/S /P
/P 1590 0 R
>>
endobj
1577 0 obj
<<
/Pg 1604 0 R
/K 9
/Type /StructElem
/S /P
/P 1580 0 R
>>
endobj
1574 0 obj
<<
/Pg 1604 0 R
/K 6
/Type /StructElem
/S /P
/P 1587 0 R
>>
endobj
1575 0 obj
<<
/Pg 1604 0 R
/K 7
/Type /StructElem
/S /P
/P 1590 0 R
>>
endobj
1572 0 obj
<<
/Pg 1604 0 R
/K 4
/Type /StructElem
/S /P
/P 1589 0 R
>>
endobj
1573 0 obj
<<
/Pg 1604 0 R
/K 5
/Type /StructElem
/S /P
/P 1586 0 R
>>
endobj
1570 0 obj
<<
/Pg 1604 0 R
/K 2
/Type /StructElem
/S /P
/P 1588 0 R
>>
endobj
1571 0 obj
<<
/Pg 1604 0 R
/K 3
/Type /StructElem
/S /P
/P 1588 0 R
>>
endobj
1568 0 obj
<<
/Pg 1604 0 R
/K 0
/Type /StructElem
/S /P
/P 1565 0 R
>>
endobj
1569 0 obj
<<
/Pg 1604 0 R
/K 1
/Type /StructElem
/S /P
/P 1565 0 R
>>
endobj
1630 0 obj
<<
/C [0 0 0]
/Parent 1623 0 R
/A 1631 0 R
/Last 1633 0 R
/First 1632 0 R
/Count 2
/Title (List of Figures)
/Prev 1634 0 R
/Next 1626 0 R
/F 0
>>
endobj
1631 0 obj
<<
/S /GoTo
/D [355 0 R /XYZ 0 792 null]
>>
endobj
1628 0 obj
<<
/A 1955 0 R
/Count 0
/Next 1951 0 R
/Title (Appendix 1 Schedule of Assessments )
/Parent 1626 0 R
/F 0
/C [0 0 0]
>>
endobj
1629 0 obj
<<
/A 1942 0 R
/Count 0
/Prev 1943 0 R
/Title (Appendix 6 Clinical Criteria for Diagnosing Anaphylaxis)
/Parent 1626 0 R
/F 0
/C [0 0 0]
>>
endobj
1626 0 obj
<<
/C [0 0 0]
/Parent 1623 0 R
/A 1627 0 R
/Last 1629 0 R
/First 1628 0 R
/Count 8
/Title (List of Appendices)
/Prev 1630 0 R
/F 0
>>
endobj
1627 0 obj
<<
/S /GoTo
/D [355 0 R /XYZ 0 792 null]
>>
endobj
1624 0 obj
<<
/S /GoTo
/D [1 0 R /XYZ 0 792 null]
>>
endobj
1625 0 obj
<<
/A 1956 0 R
/Count 0
/Next 1682 0 R
/Title (Table of Contents)
/Parent 1623 0 R
/F 0
/C [0 0 0]
>>
endobj
1622 0 obj
<<
/Count 167
/Type /Outlines
/Last 1623 0 R
/First 1623 0 R
>>
endobj
1623 0 obj
<<
/A 1624 0 R
/Count 166
/Last 1626 0 R
/Title (Protocol BH29992: Version 4 \r)
/Parent 1622 0 R
/First 1625 0 R
/F 0
/C [0 0 0]
>>
endobj
1620 0 obj
[1619 0 R]
endobj
1621 0 obj
<<
/Filter /FlateDecode
/Length 446
>>
stream
H\j0E
-E--C4Ŵä VRCcYG)C^~jalw~V~?z~J)f8g1[,T'pUwn,pTwݽwi'?̪Pu:/Lɫ<=lxׇ8uJ'.)ӎ?OMC3}(S&>us)&&^/
]ԉ mUsB%$*B@%TA+ ZCDmT?;^BV6mcl4N*N~_ h9
endstream
endobj
1618 0 obj
<<
/Type /FontDescriptor
/CapHeight 716
/FontFile2 1617 0 R
/FontFamily (Arial)
/FontWeight 700
/FontStretch /Normal
/Ascent 1056
/ItalicAngle 0
/Descent -376
/FontBBox [-628 -376 2000 1056]
/XHeight 519
/StemV 136
/FontName /XFRKNU+Arial,Bold
/Flags 4
>>
endobj
1619 0 obj
<<
/W [0 [750 0] 2 3 278 4 [333 474] 6 7 556 8 [889 722 238] 11 12 333
13 [389 584 278 333] 17 18 278 19 28 556 29 30 333 31 33 584 34 [611 975]
36 39 722 40 [667 611 778 722 278 556 722 611 833 722 778 667 778 722 667
611 722 667 944] 59 60 667 61 [611 333 278 333 584 556 333 556 611 556 611 556 333] 74 75 611 76 77 278
78 [556 278 889] 81 84 611 85 [389 556 333 611 556 778] 91 92 556 93 [500 389 280 389 584] 98 100 722 101
[667 722 778 722] 105 115 556 116 119 278 120 129 611 130 [556 400] 132 134 556 135
[350 556 611] 138 139 737 141 142 333 143 [549] 145 [778 713] 147 149 549 150 [556 576 494 713 823 549 274 370 365 768 889]
161 162 611 163 [333 584 549 556 549 612] 169 170 556 172 173 722 174 [778] 176 [944 556] 179
180 500 181 182 278 183 [549 494 556 667 167 556] 189 190 333 191 192 611 193 [556] 194
195 278 196 [500] 198 [722 667 722] 201 202 667 203 206 278 207 209 778 210
212 722 213 [278] 214 223 333 224 [611 278 667 556 611 500 280 722 611 667 556 667 611] 237 238 584 239 241 333 242
244 834 245 [556 778 611 278 667 556 722 556 722 556 611 552 333 722 556
722 556 722 719 722 667 556 667 556 611 278 611 385 611 479 722
611 722 611 778 611 722 389 722 389 667 556 611 333 611 479 722
611 722] 294 295 611 296 [500 611 500 601 778 821 615 606 475 684 446 715 552 604 396
1094] 313 [500] 315 [500] 317 318 500
319 [979 722 583 604 584] 324 325 604 326 [708 625] 328 372 708 373 [729 604] 376 379 990 380
382 604 383 [1021 1052 917] 386 387 750 388 [531 656 594 510 500 750 785 556 708 240 479 885 489 604] 402 403 354 404 [604 354 722 556 722 556 722 556 667 556 667 556 667 556 778
611 778 611 778 611 722 611 722 611] 428 435
278 436 [556 278 722] 439 440 556 441 [611 278 722 611 723 611 778 611 778 611 722 389 667 556 611
333 722 611 722 611 722 611 722 611 944 778 667 556 278 722 556] 473 [889 778 611 333 944 778 944 778 944 778 667 556 278 333 556
600] 489 492 834 493 495 333
496 [465 722 853 906 474 825 927 838 278] 505 506 722 507 [719 667 611 722 278 722 667 833 722 644 778 722 667 600 611] 522 523 667 524 [809 802 278 667 615 451 611 278 582 610 556 460 611 541 278
558 556 612 556 445 611 619 520 582 576 753 845 278 582 611 582
845 669 885 567 711 667 278 276 556 1094 1063 875 610 622 719 722
719 722 567 712 667 904 626] 578 579 719 580
[610 702 833 722 778 719 667 722 611 622 854 667 730 703 1005
1019 870 979 719 711 1031 719 556 618 615 417 635 556 709 497] 610 611 615 612 [500 635 740 604 611 604 611 556 490 556 875 556 615 581 833
844 729 854 615 552 854 583 556 611 417 552 556 278 281 278 969
906 611 500 556 604 487 447] 651 [1115 766] 653 665 0 666 [447 0 299] 669 670 0
671 [333 583 576 457 550 614 273 413 616 626 273 521 491 496 611
630 273 386 613 543 594 587 500 512 573 521 715 673] 699 701 546 702 [276 504 818 273] 706 707 521 708 709 496 710 [559] 711
714 715 715 717 583 718 [576 454 550 614 323 438 626 323 521 491 496 630 386 613 594
587 512 573 521 715 673 273 576 491 587 607] 744 747 0 748 749 319 750 [356 469 198] 753
760 0 761 770 562 771 [526 319 526] 774 775 750 776 [343 750] 778 780 562 781
785 750 786 [0] 787 794 750 795 [612] 796 798 750 799 800 649 801
802 271 803 806 750 807 [577 559] 809 810 523 811 812 433 813 [757 879 360 542 757 879 360 542 645 554 415] 824
838 750 839 843 0 844 845 750 846 861 0 862 [556] 864 891 750
892 893 319 894 [750 703 469 238 253 217 234] 901 902 451 903 [217 234 645 577] 907 908 271 909 [217 234] 911
912 649 913 914 271 915 [343 415] 917 918 649 919 920 271 921 922 649
923 924 271 925 [577 559] 927 928 523 929 [577 559] 931 932 523 933 [577 559] 935
936 523 937 940 343 941 944 433 945 946 899 947 948 608 949 950
899 951 952 608 953 954 1063 955 956 771 957 958 1063 959 960 771
961 968 523 969 [541 469 541 360 541 469 541 360] 977 978 758 979 [305 324] 981 982 612 983 [305 324] 985
986 541 987 988 360 989 990 451 991 992 234 993 994 360 995 996
415 997 998 541 999 1000 271 1001 [343 415 469] 1004 1006 451 1007 [645 554 645 577] 1011 1012
271 1013 [541 596 486 541 486 541 486 541] 1021 1022 750 1023 1024 0 1025 1027 750 1028 1029 0 1030
1031 750 1032 1033 0 1034 1036 750 1037 1042 0 1043 [750] 1044 1045 0
1046 1099 750 1100 1102 319 1103 1125 750 1126 [343 125] 1129 [2000 853 711 830 724] 1134 1149 0
1150 [513] 1151 1152 834 1153 1186 0 1187 [278 722 556 722 556 722 556 722 556 722 556 722 556 722 556
722 556 722 556 722 556 722 556 722 556 667 556 667 556 667 556
667 556 667 556 667 556 667 556 667 556] 1228 1231 278 1232 [778 611 778 611 778 611 778 611 778 611 778 611 778 611 853
711 853 711 853 711 853 711 853 711 722 611 722 611 830 724 830
724 830 724 830 724 830 724 667 556 667 556 667 556 722 556] 1278
1279 278 1280 [778 611 722 611 722 611 722 611 722 611 722 611] 1292 1295 0 1296 [567 417 904 709 610 500 610 500 722 604] 1306 1309 556 1310 [667 556 703 581 703 611 726 556 778 611 649 271 305 324 612] 1325 1330
271 1331 1333 0 1334 1335 333 1336 1339 0 1340 [217 234 217 234 217 234 217 234] 1348 1351 451 1352
[645 554] 1354 1355 649 1356 1357 271 1358 1359 649 1360 1361 271 1362 1363 649
1364 1365 271 1366 1367 649 1368 1369 271 1370 1371 649 1372 1373 271 1374
1375 649 1376 1377 271 1378 1379 649 1380 1381 271 1382 [577 559] 1384 1385 523
1386 [577 559] 1388 1389 523 1390 [577 559] 1392 1393 523 1394 [577 559] 1396 1397 523 1398
[577 559] 1400 1401 523 1402 [577 559] 1404 1405 523 1406 1423 343 1424 1439 433 1440
1441 899 1442 1443 608 1444 1445 899 1446 1447 608 1448 1449 899 1450 1451
608 1452 1453 1063 1454 1455 771 1456 1457 1063 1458 1459 771 1460 1461 523
1462 [541 469 541 360] 1466 1468 758 1469 [305 324] 1471 1472 758 1473 [305 324] 1475 1476 758 1477
[305 324] 1479 1480 758 1481 [305 324] 1483 1484 758 1485 [305 324] 1487 1490 612 1491 1492
1155 1493 1494 906 1495 [757 879 360 542] 1499 1500 541 1501 1502 360 1503 1504 541 1505
1506 360 1507 1508 541 1509 1510 360 1511 [757 879 360 542 757 879 360 542 757 879 360 542 757 879 360
542 757 879 360 542] 1531 1532 451 1533 1534 234
1535 1536 451 1537 1538 234 1539 1540 451 1541 1542 234 1543 1544 451 1545
1546 234 1547 1548 541 1549 1550 271 1551 1556 541 1557 1558 271 1559 1560
541 1561 [577 559] 1563 1564 523 1565 [343 415] 1567 1569 388 1570 1585 451 1586 [645 554 645 554]
1590 1591 271 1592 1593 451 1594 [645 554] 1596 1597 271 1598 [645 554] 1600 1603 812
1604 [207] 1605 1611 0 1612 [1123 1084] 1614 1619 0 1620 [213 371] 1622 1623 0 1624
[600] 1625 1627 0 1628 1629 899 1630 1631 608 1632 1633 1063 1634 1635 771
1636 [541 469 541 360 469 360 343 271 320] 1645 1649 244 1650 [757 879 273 0 414 546 486 541 486 541 486 541 486 541 486
541 486 541 486 541] 1670 1671 562 1672 [486 541 611 836 719 611 719 611] 1680 1681 722 1682
[556 722 837 719 611 606 667 626 611 778 637 931] 1694 1695 278 1696 [722 556 278 556 992 722 611 778 887 744 782 611] 1708 1709 667 1710 [556 600 360 333 611 333 611 802 722 770 556 611 500] 1723 1724 611 1725 1726
526 1727 1728 556 1729 [497 579 611 280 498 584 333 1333 1222 1111 1167 889 556 1278] 1744 [889 556 722 556 0 722 556] 1752 [889 778 611 778 611 722 556 778 611 778] 1762 1763 611 1764 [526 278 1333 1222 1111 778 611 1033 665 722 611 722 556 722 556
667 556 667 556] 1783
1786 278 1787 [778 611 778 611 722 389 722 389 722 611 722 611 667 556 611
333 577 520 722 611 703] 1808 1809 631 1810 [611 500 722 556 667 556 778 611 0 778 611 778 611 778 611
667] 1826 1827 556 1828 1830 611 1831
1832 556 1833 1834 611 1835 [556 782] 1837 1838 497 1839 [691 567 333] 1842 1843 611 1844
[586 556 601] 1847 1849 611 1850 1851 278 1852 [405 332 356 278 604] 1857 1859 889 1860 1861 611 1862
[615 611 833 845 750] 1867 1873 389 1874 1875 583 1876 [556] 1877 1879 333 1880 [540] 1881 1882
333 1883 [611 621 582 556 778 556 571 500 680] 1892 1893 526 1894 1897 556 1898 [778 615 567 586 604 458 556 452 611] 1907 1908 556 1909 [1031 942 1210 813 534 824 869 776 692 534 563]
1920 1921 368 1922 [194] 1923 1925 252 1926 [375 523 360 238 474] 1931 1933 278 1934 1935 333
1936 1937 375 1938 1941 584 1942 1958 333 1959 [366 141 376 366 375] 1964 1968 383 1969 1972
333 1973 [500] 1974 1982 542 1983 [383] 1984 1988 542 1989 [383] 1990 1994 542
1995 [383] 1996 2000 542 2001 [383] 2002 2006 542 2007 [383] 2008 2016 542 2017
[383] 2018 2022 542 2023 [383] 2024 2028 542 2029 [383] 2030 2034 542 2035 [383]
2036 2040 542 2041 [383] 2042 2050 542 2051 [383] 2052 2056 542 2057 [383] 2058
2062 542 2063 [383] 2064 2068 542 2069 [383] 2070 2074 542 2075 [383] 2076 2084
542 2085 [383] 2086 2090 542 2091 [383] 2092 2096 542 2097 [383] 2098 2102 542
2103 [383] 2104 2108 542 2109 [383] 2110 2113 542 2114 2204 0 2205 2207 333
2208 [610 582 770 1001 770 750 845 676 778 611 722 556 611 452 751
529 804 610 992 889 703 611 703 605] 2232 2233 667 2234 [643 604 735 578 507 439 676 618 556 278 778] 2245 2246 479 2247 [667 719 556 615 1280 778 869 703 976 796 667 556 926 800 809
753 1077 980 626 497 809 753 778 611 815 646 815 646 1120 974 814
638 1280 901 0 1280 778 722 556 584] 2287 2292 0 2293
[719 615 719 615 667 611 703 598 626 497 610 500 761 623 879
714 1126 921 722 578 722 556 611 490 853 689 703 581 856 678 856
678 278 904 709 702 598 702 635 722 604 722 604 703 581 833 740
333 722 556 722 556] 2346 [889 667 556 726 556 904 709 626 497 626 526 719 615 719 615
778 611 778 611 711 552 622 556 622 556 622 556 703 581 979 854
719 611 1030 935 959 846 658 536 1013 956 1033 925 778 586 766 701] 2393 2430 0 2431 [722 556 722 611 722 611 722 611 722 556 722 611 722 611 722
611 722 611 722 611 667 556 667 556 667 556 667 556 667 556 611
333 778 611 722 611 722 611 722 611 722 611 722 611] 2475 2478 278 2479 [722 556 722 556 722 556 611 278 611 278 611 278 611 278 833
889 833 889 833 889 722 611 722 611 722 611 722 611 778 611 778
611 778 611 778 611 667 611 667 611 722 389 722 389 722 389 722
389 667 556 667 556 667 556 667 556 667 556 611 333 611 333 611
333 611 333 722 611 722 611 722 611 722 611 722 611 667 556 667
556 944 778 944 778 667 556 667 556 667 556 611 500 611 500 611
500 611 333 778] 2578 2579 556
2580 [278] 2581 2588 615 2589 2590 722 2591 2596 869 2597 2602 475 2603 2604
765 2605 2608 960 2609 2616 611 2617 2618 820 2619 2624 1015 2625 2632 278
2633 2634 375 2635 2640 571 2641 2646 611 2647 2648 827 2649 2650 1042 2651
2652 973 2653 2660 582 2661 [813 999 1048 960] 2665 2672 845 2673 2674 851 2675 2676 1065
2677 2680 997 2681 2682 615 2683 2684 475 2685 2686 611 2687 2688 278 2689
2690 611 2691 2692 582 2693 2694 845 2695 2702 615 2703 2704 722 2705 2710
869 2711 2718 611 2719 2720 820 2721 2726 1015 2727 2734 845 2735 2736 851
2737 2738 1065 2739 2742 997 2743 2749 615 2750 2754 722 2755 2759 333 2760
2764 611 2765 2766 862 2767 2768 917 2769 [722] 2770 2772 333 2773 2780 278
2781 2782 473 2783 2785 333 2786 2789 582 2790 2791 619 2792 2793 582 2794
2795 667 2796 [862 911 765] 2799 2800 465 2801 [333] 2802 2806 845 2807 [924 827 948 851 802] 2812 2813
333 2814 [556] 2815 2816 722 2817 [889 722 1225 944 722 611 1086 500 594] 2826 2829 0 2830 2831 278 2832 [556 667 837 499 833 506]
2838 2839 729 2840 2853 333 2854 2855 397 2856 [333] 2857 2867 0 2868 [667 611 588 776 889 615 556]
2875 2876 575 2877 [500 497 278 507 558 452 740 615 611 556] 2887 2889 618 2890 [944 571] 2892 2893 611 2894 [614] 2895
2896 583 2897 [490 582 611 768 609 556 778 500 484 493 615 417 556 604 614
753 635 486 696] 2916 2917 454 2918 [455] 2919 2920 417 2921 [501 436 181 358 461 390 517 433 434 519 435 419 459 433 435
635] 2937 2938
377 2939 [391 589] 2941 2942 391 2943 2944 376 2945 2946 351 2947 [391 141 349 564 368 410 380] 2954 2955
411 2956 [391 217 368 407 564 364 412 388 364 408 481 379 141 252 368
364 388 364 407 481 379 936 1324 332 1309 657 239 541] 2984 2992 0 2993 2994 343 2995 2996 433 2997 [469 451 469 451 723 696 761 637 643 757 668 820 584] 3010 3012
0 3013 [556 500 479] 3016 3019 234 3020 [852 1189 500] 3024 [500] 3026 [333 250 167 556 278 200 83 0 737 722 833 740 922] 3039 3040 954 3041
3042 722 3043 [556] 3044 3045 611 3046 [556 500 645] 3049 3053 0 3054 [619] 3055 3057
722 3058 [567 417] 3060 3062 0 3063 [386 0 324 405] 3067 3073 0 3074 3075 649 3076 3077
271 3078 3079 649 3080 3081 271 3082 3083 649 3084 3085 271 3086 3087 649
3088 3089 271 3090 3091 649 3092 3093 271 3094 3095 649 3096 3097 271 3098
3099 649 3100 3101 271 3102 [577 559] 3104 3105 523 3106 [577 559] 3108 3109 523 3110
3113 343 3114 3115 433 3116 3117 899 3118 3119 608 3120 [541 469 541 360 541 469 541 360 541 469 541 360] 3132 3133 758
3134 [305 324] 3136 3137 758 3138 [305 324 757 879 360 542 757 879 360 542 757 879 360 542] 3152 3153 360 3154 3155 415 3156 3157 360
3158 3159 415 3160 3161 541 3162 3163 271 3164 3165 541 3166 3167 271 3168
3169 541 3170 3171 271 3172 3173 451 3174 3175 234 3176 3179 433 3180 3181
899 3182 3183 608 3184 3185 611 3186 [333 889] 3188 3189 611 3190 3191 389 3192
[556 333 500 611 367 607 873] 3199 3200 278 3201 [611 582 621] 3204 3205 611 3206 [333 768 556 278 889] 3211 3212 611 3213 [389 556 466]
3216 3217 556 3218 [500 556] 3220 3221 611 3222 [556] 3223 3224 497 3225 [655 278 556 333 611 526 391] 3232
3233 380 3234 [410 351] 3236 3237 242 3238 [391 368 182] 3241 3242 141 3243 [182 308 194 164 286] 3248 3249
564 3250 3251 421 3252 [372 410 501 376 278 217 406 421] 3260 3262 364 3263 3264 361 3265 [468 380 363] 3268 3271
0 3272 [333 377 376 410 366 376 778 722 667 722 333] 3283 3290 615 3291 3298 278 3299 3306 582 3307 3310 278 3311
3314 582 3315 [486 541 484] 3318 3319 722 3320 3321 667 3322 3323 556 3324 [278 775 611 722 389 667] 3330
3333 556 3334 [278 567 417 667 556 667 556 626 497 702 635] 3345 3353 0 3355 [500 556 611 278 611 667 722 556 333 722 611 722 556 611 500
556 541 436 715] 3374 3379 0 3380 [278 723 722 723] 3384 3394
0 3395 [778 611 944 778 715 0 763 606 1044 858 333 389] 3407 3408 238 3409 3410 500 3411 3414 333 3415 3422 0 3423
[611 556 580 434 566 541 566 546 568 525 556 570 554 438] 3437 3438 563 3439 [576 563 567 529 556 567 705 728 731 1146 731 386 699 778 611
264 555 308 611 289 611] 3460 3461 556 3462 [386 308 278 602 616 597 618 565 520 655 634 289 477 619 521
770 631 661 568 666 620 560 512 615 571 790 579 581 520 850 840
521 660 569 618 632] 3498 3503 602 3504 [597]
3505 3508 565 3509 3512 289 3513 [631] 3514 3518 661 3519 3522 615 3523 [581]
3524 3526 602 3527 3528 597 3529 [655] 3530 3531 618 3532 3536 565 3537 3538
655 3539 [597] 3540 3541 634 3542 3546 289 3547 [730 477 619] 3550 3553 521 3554 3556
631 3557 [625] 3558 3560 661 3561 3563 620 3564 3567 560 3568 3571 512 3572
3577 615 3578 3581 790 3582 3584 581 3585 3587 520 3588 [602 850 660 602 616 511 602 565 520 634 661 289 619 560 770
631 528 661 625 568 515 512 581 689 579 679 670 602 565 634 289
661 581 670 289 581 565 729 511 599 560] 3629 3630 289
3631 [477 896 912 692 560 542 623 602] 3639 3640 616 3641 [511 610 565 825 542] 3646 3647 631 3648 [560 588 770 634 661 625 568 597 512 542 702 579 628 593 845
854 719 837 591 599 860 620 424] 3671 3683 333 3684
3694 705 3695 3705 728 3706 3718 731 3719 3727 386 3728 [538] 3729 3731 386
3732 3733 308 3734 [378 394 308] 3737 3744 386 3745 [699] 3746 3754 611 3755 [264 555] 3757
3758 308 3759 [378 394 308] 3762 3763 289 3764 [435 289] 3766 3769 611 3770 [604 560 597 655] 3774 3777
333 3778 [703] 3779 3780 616 3781 [826 604 736] 3784 3798 274 3799 [1674 1774 0 1923] 3803 3806 0
3807 [577 559] 3809 3810 523 3811 [577 559] 3813 3814 523 3815 3816 899 3817 3818 608
3819 3820 433 3821 [577 559] 3823 3824 523 3825 [217 234 217 234 645 554] 3831 3832 271 3833 [645 554] 3835
3836 271 3837 [645 554] 3839 3840 271 3841 3844 451 3845 3848 812 3849 [577 559] 3851
3852 523 3853 3854 899 3855 3856 608 3857 3858 899 3859 3860 608 3861 3862
541 3863 3864 360 3865 [538 581 530 579 965 742 892 636 1483] 3874 3878 0 3879 [645 554] 3881 3882 271 3883 [757 879 360 542 757 879 360 542 645 554]
3893 3894 271 3895 [645 554] 3897 3898 271 3899 [645 554] 3901 3902 271 3903 [0 541 462 611 585 719 634 722 611 1300 558 667 1019 864 809
802 997 864 722 558 1107 947 1127 916 719 604 703 611] 3931
3932 333 3933 [606 840 513 635 606 705 652 833 722 763 700 389 611 500 194
364 667 611 278 947 1405 1103 1410 1923] 3957 3959 198 3960 [234] 3961 3962 207 3963 [198 207 290] 3966 3967
207 3968 [198 207 198 207 198 207 198 207 198] 3977 3981 244 3982 [272 244 200] 3985 3986 343 3987 [595] 3988 3989 371
3990 3991 548 3992 3999 673 4000 4001 553 4002 [528] 4003 4004 553 4005 [528]
4006 4007 649 4008 4009 271 4010 [577 559] 4012 4017 523 4018 4019 758 4020 [305 324]
4022 4023 612 4024 [305 324] 4026 4027 451 4028 4029 234 4030 4031 360 4032 4033
415 4034 [645 577] 4036 4037 271 4038 [645 577] 4040 4041 271 4042 4043 403 4044 4045
451 4046 4047 427 4048 4074 0 4075 [486 541 0 457 550 614 673] 4082 4083 0 4084 4085 319 4086
4094 559 4095 [612 319 394 273 185 0 852 737 718 744 737 718 729 685 718
910 744 693 582 941 771 708 648 719] 4119 4120 737 4121 [767 747 737 706 718 700 849 769 767 718 737 680 688 747 532
864 763 792 825] 4140 4141 278 4142 [225 250 299 273 514 900 612 674 670 614 618 589 632 778 674
612 279 901 606 614 612 569 614 609 612 279 614 518 612 386 900
571 602] 4175 4176
612 4177 [898 611 621 445 898 614 623 830 781 333 393] 4188 4189 1002 4190 [747] 4191 4194 1226 4195 [1513 556] 4198 4199 0
4200 4201 649 4202 4203 271 4204 [167] 4205 4206 343 4207 4208 1063 4209 4210
771 4211 [757 879 360 542 334 239] 4217 4218 433 4219 [0 556 722 604 1452 1200 766 628 702 635 925 902 642 917 913
651 860 824 541 469 541 360] 4241 4242 541 4243 4244 360 4245 [0 303 231 299 239 722 611 853 721]
4254 4255 563 4256 4257 535 4258 4259 633 4260 [520 560 1210 874 1192 926 1103 900 975 795 975 795 975 795 722
556 722 556 722 556 722 556 755 418 611 278 899 669 879 693 1323
1008 667 611 857 768 950 856 807 611 987 772 611 466] 4304 4305 646 4306 [667 556 944 778 584 545 667 611 667 611 580 484]
4318 4319 464 4320 4321 557 4322 4323 573 4324 [334 784 447 1063 784 389 779 752 515 778 611 500 389 590] 4338 4340 611 4341 [278 815 650 500 389 674 555 722 543 760 623 722]
4353 4354 556 4355 [611 913 812 663 333 706 591 734 589 706 591 778 611 722 556
722 611 722 389 667 556 838 604 763 772 722 611 524 778 722 610
1012 845 735 450 641 889 611 667 833 278 1175 615 877 502 556 678
333 611 486 396 373 921 621 611] 4410 4411 575 4412 [611] 4413 4415 944 4416 4417 1008
4418 [586 628 371 558 510 679 525 785 333] 4427 4428 611 4429 4430 889 4431 [645 576 648 608 601 592 637 592 537 333 368 320 292 443 854
807 944 972 611 670 722 611]]
/Type /Font
/CIDSystemInfo 1615 0 R
/DW 1000
/CIDToGIDMap /Identity
/BaseFont /XFRKNU+Arial,Bold
/FontDescriptor 1618 0 R
/Subtype /CIDFontType2
>>
endobj
1617 0 obj
<<
/Filter /FlateDecode
/Length 25649
/Length1 61074
>>
stream
H|U TT{Qd>E+""̠ԨԀ[g%hh"hFbM\Mܗ>F&ǜĸj&HZʼ39ͻͻo@ KH3)dTw+-(
??kmeGvUo-Hi2|_!o/2^w.]lu^oճw}V&zlIS,q.6?P